Skip to main content
. 2021 Aug 26;12:20420986211041277. doi: 10.1177/20420986211041277

Figure 3.

Figure 3.

Docked pose of second-line antitubercular drugs, fluoroquinolones: (a) levofloxacin, (b) moxifloxacin and (c) ofloxacin at the P-gp binding pocket.